A digital tool to empower adults with congenital heart disease
Improving Care for Adults With Congenital Heart Disease
NA · University of California, San Francisco · NCT06581484
This study is testing a digital tool called 'Empower My Congenital Health' to see if it helps adults with congenital heart disease feel more confident and engaged in managing their health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT06581484 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a digital health intervention called 'Empower My Congenital Health' designed to enhance the engagement and self-advocacy skills of adults with congenital heart disease (CHD). The intervention includes features such as a digital medical passport, health information, community support, and reminders for specialist visits. Participants will be recruited from clinics and through various outreach methods, and their engagement will be assessed through surveys at regular intervals. The study aims to determine if this intervention improves patient confidence in navigating the healthcare system.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have congenital heart disease and can provide informed consent.
Not a fit: Patients who are developmentally delayed or unable to consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the ability of adults with congenital heart disease to manage their health and access necessary care.
How similar studies have performed: Other studies have shown promise in using digital interventions for patient engagement, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * have congenital heart disease * 18 years or older * can sign the informed consent Exclusion Criteria: * developmentally delayed * unable to consent
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (RECRUITING)
Study contacts
- Principal investigator: Anushree Agarwal, MBBS, MAS — University of California, San Francisco
- Study coordinator: Anushree Agarwal, MBBS, MAS
- Email: anu.agarwal2@ucsf.edu
- Phone: 415-353-3817
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Congenital Heart Disease, Behavior, Health, Quality of Life, Empowerment, Patient, Activation, Patient